VALE WYLIE W 4
4 · NEUROCRINE BIOSCIENCES INC · Filed Nov 21, 2005
Insider Transaction Report
Form 4
VALE WYLIE W
Director
Transactions
- Sale
Common Stock
2005-11-18$60.01/sh−416$24,964→ 256,072 total - Sale
Common Stock
2005-11-18$60.05/sh−100$6,005→ 253,372 total - Sale
Common Stock
2005-11-18$60.06/sh−1,200$72,072→ 252,172 total - Sale
Common Stock
2005-11-18$60.09/sh−700$42,063→ 251,372 total - Sale
Common Stock
2005-11-18$60.02/sh−400$24,008→ 255,672 total - Sale
Common Stock
2005-11-18$60.03/sh−900$54,027→ 254,772 total - Sale
Common Stock
2005-11-18$60.00/sh−4,884$293,040→ 256,488 total - Sale
Common Stock
2005-11-18$60.04/sh−1,300$78,052→ 253,472 total
Footnotes (2)
- [F1]The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person and delivered to the broker on August 9, 2005.
- [F2]182,777 shares are held by the Reporting Person; 68,595 shares held indirectly by WBV Limited Liability Company